Anélys
is a biotech solution that enhances the use value and security of luxury goods.



Anelys, allows for integration of stabilized DNA into micro-capsules of 2.2 mm width over 1.3 mm thickness. These capsules are traced with a QR code linked to blockchain, and are then integrated into the object.
Anelys allows for a double signature of the precious item:

biological signature (from the chosen person’s DNA, which fully expresses the love emotion linked to the object)

digital signature (from the QR code linked to the blockchain making it possible to trace the object)
Anelys relies on a unique technology, with a worldwide patent, that can stabilize DNA, maintain and protect it from natural degradation related to water, air and light. Through our technology, the DNA is preserved for tens of thousands of years.


In the next few years, Anelys is set on becoming a strong reference option in the jewelry and luxury watches’ market. It will resonate with clients who would want to include their high-end jewelry and watches in their family legacy, also those who would want to include eternity at the heart of a precious object, filled with emotions and significance.
Our first target markets are:
-The US engagement and wedding ring market, estimated at 12 billion euros
-The global market for luxury watches estimated at 39 billion euros
THE TEAM
Harry ROSELMACK
President and co-founder
Aïda Camara CROWDER
Senior Advisor – In charge of the North American market
Christophe GOLAY
Co-founder, R&D and Sales & Marketing Director (watchmaking)
Patrice HENRY
Executive Vice President, Finance
Kathie LEE
Senior Advisor – In charge of the North American market
Pierrick MATHIEU
Associate, Commercial Strategy